FDA Drug recall D-160-2013
Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Min…
- FDA Drug
- Class II
- terminated
- Published 2013-02-20
On 2013-02-20 the FDA classified a Class II recall of Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Min… by Upsher Smith Laboratories, citing failed Dissolution Test Requirements.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-160-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-11-20 |
| Published | 2013-02-20 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Upsher Smith Laboratories |
| Distribution | FL, NJ |
Product
Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9
Reason
Failed Dissolution Test Requirements
Identifiers
| upc | 302450085119 |
|---|---|
| code_info | Lot #308198, Expiration Date is 03/2014 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-160-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.